Cogent Biosciences Stock Forecast

Stock Price Forecast

The 6 analysts that cover Cogent Biosciences stock have a consensus rating of "Buy" and an average price target of $15.2, which forecasts a 111.7% increase in the stock price over the next year. The lowest target is $7 and the highest is $25.

Price Target: $15.2 (+111.7%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$7.00	$15.2	$15	$25
Change	-2.51%	+111.70%	+108.91%	+248.19%

* Price targets were last updated on May 29, 2025.

Analyst Ratings

The average analyst rating for Cogent Biosciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	2	2	2	2	2	2
Buy	1	1	2	2	2	2
Hold	3	3	3	3	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	7	7	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ami Fadia Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Jun 17, 2025
Anupam Rama JP Morgan	JP Morgan	Buy Maintains $21 → $25	Buy	Maintains	$21 → $25	+248.19%	May 29, 2025
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $14 → $12	Strong Buy	Maintains	$14 → $12	+67.13%	May 20, 2025
Joel Beatty Baird	Baird	Hold Maintains $8 → $7	Hold	Maintains	$8 → $7	-2.51%	May 7, 2025
Louise Chen Scotiabank	Scotiabank	Buy Initiates $17	Buy	Initiates	$17	+136.77%	Mar 7, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

31.34M

EPS This Year

-2.20

from -2.46

EPS Next Year

-1.93

from -2.20

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	7.87M	-	-	-	-	-	31.34M	204.36M
Revenue Growth	-65.02%	-	-	-	-	-	-	552.16%
EPS	-16.17	-1.87	-2.38	-2.41	-2.46	-2.20	-1.93	-0.90
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	13	13	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	119.5M	640.9M
Avg	n/a	31.3M	204.4M
Low	n/a	n/a	20.8M

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	1,945.3%
Avg	-	-	552.2%
Low	-	-	-33.6%

EPS Forecast

EPS	2025	2026	2027
High	-1.97	-1.46	1.19
Avg	-2.20	-1.93	-0.90
Low	-2.60	-2.84	-1.75

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.